Facility will support Agilent’s mission to accelerate the production of oligonucleotide therapeutics that provide care to people facing a broad range of diseases.
Turner Construction Company is pleased to announce that Agilent Technologies selected the company to build a $725 million facility to produce active pharmaceutical ingredients (API) in Frederick, Colorado.
The 200,000 square foot project increases Agilent’s capacity to meet demand for the company’s synthetic oligonucleotides, which help treat cancer, cardiovascular disease, and other rare diseases. The project will be built in accordance with Process Safety Management (PSM) standards.
“It is great to be part of project that will improve the care available for people that are facing a wide range of healthcare challenges,” said Scott Bustos, Vice President and General Manager of Turner Construction Company. Scott continued, “I thank Agilent for their trust in the technical expertise of our people and for their investment in the Frederick, Colorado, community that will have such a broad and positive impact on society.”
The project is scheduled for completion in 2026.
About Turner Construction Company
Our vision is to be the highest value provider of construction services. We deliver our services on complex and challenging building projects of all types and sizes throughout North America and in 30 countries around the world. We seek to create a healthy, prosperous, and sustainable future for our people, clients, partners, and the planet. We have earned a reputation for integrity, working safely, and driving innovation. With a focus on creating an environment where people can be at their best, be authentic, and be treated with respect and dignity, the company is widely recognized as a great place to work.
Turner is a subsidiary of HOCHTIEF, an engineering-led global infrastructure group with leading positions across its core activities of construction, services, and concessions/public-private partnerships (PPP) focused on Australia, North America, and Europe.